Trial intelligence / Profile preview

Jafron Haemoadsorption During Cardiopulmonary Bypass

NCT05349669Phase 2Completed

Sponsor
Anthea Hospital
Start
May 2022
Primary completion
Sep 2022
Countries
1
01

Overview

Phase 2, randomised trial (2 arms), sponsored by Anthea Hospital. Primary endpoints: Serum Cytokine Levels (IL-2, IL-6, TNF-alpha, IFN gamma), Hemodynamic Support Requirements and 2 more. Started May 2022; status: completed.

Beyond the preview

Go deeper on NCT05349669.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05349669.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call